← All forecasts · November 2–6

CORZ / FQ3 2026 (quarter ended 2026-09-30)

Core Scientific, Inc.

Reported: Nov 5, 2026

Forecast published

Opus 5.5 High in Shortcut

Review incomplete

Shortcut

0.08

Normalized diluted EPS

Street rounds to zero

Off by $0.28 per share

Street

0.00

Normalized diluted EPS

November 1 consensus snapshot

Off by $0.36 per share

Real

0.36

Reported normalized EPS

Shortcut win

Reported result · Nov 5 ↗ · Core Scientific reports diluted EPS of $0.47 and no adjusted EPS. Rebuilt from its quarterly report ↗, the figure is $0.13 to $0.47 depending on which one-off items are removed; $0.36 is shown. Shortcut is closer on every reading. Held for this basis check from the report until November 9.

USD per diluted ordinary/common share. Comparisons use unrounded estimates.

Model download

Explore the assumptions and calculations behind the forecast. This is the agent’s original workbook. Its review didn’t finish, so it hasn’t been checked or repaired.

Shortcut’s reasoning.

Billing capacity rose from 395 MW (Jun 30) to 437 MW (mid-July) and ~485 MW (Oct 13 company post); day-weighted ~435 MW vs ~272 MW revenue-implied in 2Q26.

The issuer's $635m run-rate for 437 MW (~$1.45m/MW/yr) excludes power pass-through (2Q26 power = 35.5% of license fees), so colocation revenue builds to ~$214m and total revenue ~$235m vs the $193.8m consensus mean.

Licensing gross margin ~81% (management 80-85%), startup costs held at $27m, cash SG&A $34m and net interest ~$32m on the $3.3bn notes leave normalized net income of ~$35m.

Bitcoin rose 43% in the quarter (Jun 30 $58.6k to Sep 30 $83.6k): ~$21m fair-value gain on 848 BTC, kept in normalized earnings as consensus data's 1Q26/4Q25 actuals imply.

Normalized EPS ~$0.08 = ($35.0m + $3.45m if-converted coupon) / ~475m diluted shares (GAAP net income is positive from a ~$988m warrant gain as the stock fell to $15.98); consensus normalized basis is noisy (history gaps up to $0.09), so P(beat) is held at 0.72 rather than the model-implied ~0.85.

On the record.

Reporting period
FQ3 2026 (quarter ended 2026-09-30)
Reporting basis
normalized EPS, diluted, USD per common share (model proxy: GAAP net income excluding warrant/CVR fair-value changes, impairment, disposal and held-for-sale losses, contract termination, debt extinguishment, legal settlements and merger/advisory costs; diluted share count because GAAP net income is positive)
Consensus snapshot
November 1, 2026
Model / effort
Opus 5.5 · High effort
Workbook
Original workbook · review incomplete
Record history
Forecast generated
Nov 1, 2026 at 10:34 PM PST
First posted
Nov 2, 2026 at 3:21 PM PST
Result checked
Nov 8, 2026 at 12:59 PM PST
Result basis

Core Scientific reports diluted EPS of $0.47 and no adjusted EPS. Rebuilt from its quarterly report ↗, the figure is $0.13 to $0.47 depending on which one-off items are removed; $0.36 is shown. Shortcut is closer on every reading. Held for this basis check from the report until November 9.